Moreover, our study acknowledges the existence of additional driver genes in DLBCL, such as ACTB, BTG2, PLET1, CARD11, and DIXDC1, which could be potential targets for future investigation (Fan et al., 2020). The gene discussed is CARD11; the disease is diffuse large B-cell lymphoma.